Skip to main content

and
  1. No Access

    Article

    Harmonemia: a universal strategy for flow cytometry immunophenoty**—A European LeukemiaNet WP10 study

    F Lacombe, E Bernal, D Bloxham, S Couzens, M G D Porta, U Johansson, W Kern in Leukemia (2016)

  2. No Access

    Article

    Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes—proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS

    Definite progress has been made in the exploration of myelodysplastic syndromes (MDS) by flow cytometry (FCM) since the publication of the World Health Organization 2008 classification of myeloid neoplasms. An...

    A Porwit, A A van de Loosdrecht, P Bettelheim, L Eidenschink Brodersen in Leukemia (2014)

  3. No Access

    Article

    Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group

    Flow cytometry (FC) is increasingly recognized as an important tool in the diagnosis and prognosis of myelodysplastic syndromes (MDS). However, validation of current assays and agreement upon the techniques ar...

    T M Westers, R Ireland, W Kern, C Alhan, J S Balleisen, P Bettelheim, K Burbury in Leukemia (2012)